TGFB1I1
Transforming growth factor beta-1-induced transcript 1 protein
Also known as: ARA55, Hic-5, TGFI1_HUMAN, TSC-5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43294
- Gene
- TGFB1I1
- Ensembl
- ENSG00000140682
- Chromosome
- 16
- Canonical length
- 461 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Focal adhesion sites,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a coactivator of the androgen receptor, a transcription factor which is activated by androgen and has a key role in male sexual differentiation. The encoded protein is thought to regulate androgen receptor activity and may have a role to play in the treatment of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>O43294|TGFB1I1
1 MEDLDALLSD LETTTSHMPR SGAPKERPAE PLTPPPSYGH QPQTGSGESS GASGDKDHLY
61 STVCKPRSPK PAAPAAPPFS SSSGVLGTGL CELDRLLQEL NATQFNITDE IMSQFPSSKV
121 ASGEQKEDQS EDKKRPSLPS SPSPGLPKAS ATSATLELDR LMASLSDFRV QNHLPASGPT
181 QPPVVSSTNE GSPSPPEPTG KGSLDTMLGL LQSDLSRRGV PTQAKGLCGS CNKPIAGQVV
241 TALGRAWHPE HFVCGGCSTA LGGSSFFEKD GAPFCPECYF ERFSPRCGFC NQPIRHKMVT
301 ALGTHWHPEH FCCVSCGEPF GDEGFHEREG RPYCRRDFLQ LFAPRCQGCQ GPILDNYISA
361 LSALWHPDCF VCRECFAPFS GGSFFEHEGR PLCENHFHAR RGSLCATCGL PVTGRCVSAL
421 GRRFHPDHFT CTFCLRPLTK GSFQERAGKP YCQPCFLKLF GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TGFB1I1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 258 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 258 nTPM
- colon: 251 nTPM
- blood vessel: 231 nTPM
- urinary bladder: 165 nTPM
- fallopian tube: 158 nTPM
- cervix: 128 nTPM
Single-cell type
- megakaryocytes: 593 nCPM
- smooth muscle cells: 439 nCPM
- decidual stromal cells: 331 nCPM
- breast myoepithelial cells: 280 nCPM
- platelets: 211 nCPM
- vascular smooth muscle cells: 202 nCPM
Immune cell
- basophil: 9.5 nTPM
- T-reg: 1.6 nTPM
- total PBMC: 1.3 nTPM
- memory B-cell: 0.9 nTPM
- memory CD4 T-cell: 0.9 nTPM
- naive CD8 T-cell: 0.6 nTPM
Brain region
- medulla oblongata: 4.6 nTPM
- thalamus: 3.4 nTPM
- basal ganglia: 3.2 nTPM
- pons: 3.1 nTPM
- cerebral cortex: 3 nTPM
- amygdala: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.55
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell fate commitment
- epithelial cell differentiation
- fat cell differentiation
- morphogenesis of embryonic epithelium
- negative regulation of cell population proliferation
- negative regulation of fat cell differentiation
- positive regulation of DNA-templated transcription
- positive regulation of epithelial to mesenchymal transition
- positive regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of ubiquitin-dependent protein catabolic process
- Wnt signaling pathway
Molecular functions
- I-SMAD binding
- metal ion binding
- nuclear androgen receptor binding
- Roundabout binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TGFB1I1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TGFB1I1 as an antibody target. Whether an autoantibody or antibody against TGFB1I1 could matter depends on whether native TGFB1I1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TGFB1I1 is annotated at the cell surface, where native TGFB1I1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TGFB1I1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...